JANG SU
HANChang-Su
60MED RISK
Computed from public regulatory data. Not a legal opinion.
1 Appearance1 Jurisdiction
AI Analysishigh confidence
Jang Su is designated under the Iran, North Korea, and Syria Nonproliferation Act (INKSNA). This designation restricts dealings with the entity and requires due diligence to ensure compliance with U.S. sanctions.
Jang Su designated under INKSNA, posing sanctions risk.
other
Sources: Iran, North Korea, and Syria Nonproliferation Act (INKSNA)
Generated from official regulatory data. Not legal advice. Verify against the issuing authority before reliance.
Sanction History
MED RISK
Risk Assessment
This entity presents moderate compliance exposure with 1 appearance across 1 jurisdiction. Monitoring required under 1 jurisdiction. Listed for over 8 years, indicating persistent regulatory concern. No ECCN technology tags on record — technology-specific licence triggers may not apply, but end-user restrictions still stand. Enhanced due diligence is advised.
1 list appearance1 jurisdictionFirst listed 2017
Listed By
Details
First listed7 Aug 2017
Last listed7 Aug 2017
Risk score60 / 100
Full Intelligence
See related regulatory alerts, intelligence feed, and export a compliance report.
Start for free →Screen another counterparty
← Back to entity search